No published trials demonstrate that glutathione supplementation improves weight loss outcomes, reduces oxidative stress markers, or enhances metabolic health during GLP-1 therapy
(2010) rat study showed continued improvement across 14, 30, 45, and 90-day checkpoints
The incidence of AEs tended to be higher for patients receiving insulin than other background medications, which may reflect the safety profile and the fact that insulin is often used later in the treatment course of T2D, when patients are more vulnerable
But he isn't using brand-name Wegovy or Zepbound
Research consistently shows that maintaining weight loss after tirzepatide requires ongoing effort, and many patients regain a significant portion of lost weight after discontinuation
Reduced Appetite: The other advantage of tirzepatide is its reduction of hunger